Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Opinion in Organ Transplantation|May 16, 2019
Desensitization for sensitized patients awaiting heart transplantMirnela Byku, Patricia P Chang
JACC. Basic to Translational Science|August 16, 2016
NEUROMODULATION OF THE FAILING HEART: LOST IN TRANSLATION?Mirnela Byku, Douglas L Mann
American Journal of Physiology. Heart and Circulatory Physiology|October 7, 2008
Nerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive ratsMirnela Byku, Heather Macarthur, Thomas C Westfall
American Journal of Physiology. Heart and Circulatory Physiology|November 26, 2009
Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bedMirnela Byku, Heather Macarthur, Thomas C Westfall
Artificial Organs|September 27, 2023
Warfarin and aspirin versus warfarin alone for prevention of bleeding and thrombotic events in patients with a HeartMate 3™ left ventricular assist deviceMichelle Yi, Prashanth Iyer, Mirnela Byku, et al.
Clinical Cardiology|August 1, 2023
LVAD therapy as a catalyst to heart failure remission and myocardial recoveryEman A Hamad, Mirnela Byku, Sharon B Larson, et al.
Advances in Pharmacology (San Diego, Calif.)|September 24, 2013
Interactions of neuropeptide y, catecholamines, and angiotensin at the vascular neuroeffector junctionThomas C Westfall, Heather Macarthur, Mirnela Byku, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|April 7, 2025
Relationship of PAD and Use of TMCS on Outcomes Post-LVAD: A Case Series of 197 PatientsPanagiotis Tasoudis, Mitchell Williams, Amrita Sukhavasi, et al.
Clinical Transplantation|October 27, 2025
Outcomes and Tolerability of Early Mammalian Target of Rapamycin Inhibitor Initiation for Renal Sparing in Heart Transplant RecipientsAvery Marcotte, Rachel Rikard, Chelsea Castor, et al.
Frontiers in Oncology|July 11, 2022
Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) AmyloidosisChristopher E Jensen, Mirnela Byku, Gerald A Hladik, et al.
Pageof 3